Wang et al.’s [14] study showed that the JNK signal transduction pathway was activated after ICH, while intravenous injection of the JNK peptide inhibitor D-JNKI-1 could alleviate cerebral edema and improve the neurological deficits via reducing the transcriptional activity of c-Jun. The gene discussed is JUN; the disease is brain edema.